Variant Bio Turns Focus from Identifying Genomic Variants to Drug Discovery
To date, the company has built a foundation of more than 20 genomic research partnerships across six continents.
Stay updated with breaking news from Variant Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
To date, the company has built a foundation of more than 20 genomic research partnerships across six continents.
David Moller joins as Chief Scientific Officer and Steve Bryant as Chief Business Officer, adding deep expertise to executive teamSEATTLE--(BUSINESS WIRE)--Variant Bio, a genomics-driven drug discovery company, is transitioning from a company that focused on identifying genomic variants that uncover the basis of dis...
UW Medicine genome experts made significant scientific contributions to a National Institutes of Health Human Genome Research Institute reference collection that better represents the genetic diversity of the world’s populations. Called the Human Pangenome Reference Consortium, the multi-institutional effort expands and updates earlier work that started as the Human Genome Project. In addition to collaborating with many others on the overall pangenome, scientists in the Department of Genome Sciences at the University School of Medicine also made specific contributions in uncovering new vari...
Construction industry news, trends and jobs for building professionals who want mobile-friendly content.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.